Skip to main content
. 2016 Apr 8;8(10):499–508. doi: 10.4254/wjh.v8.i10.499

Figure 1.

Figure 1

Tyrosine predicts 3-mo liver transplant-free survival in patients with end-stage liver disease. Results are presented as AUC (P25, P75). AUC: Area under receiver operating characteristics curve; OLT: Orthotopic liver transplantation; MELD: Model for end-stage liver disease.